Viz.ai Named One of Fierce Medtech’s “Fierce 15” Companies of 2022
Annual list recognizes innovative medtech companies that are advancing the art and science of healthcare SAN FRANCISCO – March 20,...
Mar 20, 2023
Press & News
Explore our News & Press
Viz.ai to Expedite Patient Enrollment in NIH-funded PE-TRACT Clinical Trial
Viz.ai’s AI-powered clinical research platform will be used to find, screen and enroll patients in a landmark study of catheter-directed...
Mar 04, 2023
Viz.ai Announces Agreement with Bristol Myers Squibb to Enable Earlier Detection and Management...
Viz.ai has submitted a de novo classification request to the FDA for a new AI algorithm intended to identify and...
Mar 02, 2023
Viz.ai Collaborates with Johns Hopkins to Expedite Patient Enrollment in Brain Injury Trial
Using Viz RECRUIT software, recruitment happens in real-time, around-the-clock, accelerating treatment development for patients with intracerebral hemorrhage SAN FRANCISCO, CA...
Feb 14, 2023
Large real-world, multi-center study demonstrates Viz.ai Platform saves critical minutes in stroke care
Study, across 166 facilities in 17 states, finds AI-powered care coordination crucial for acute stroke management SAN FRANCISCO - February...
Feb 08, 2023
Viz.ai Launches AI-Powered Viz™ Vascular Suite
End-to-end platform for vascular care teams to accelerate the detection and treatment of suspected vascular disease SAN FRANCISCO – January...
Jan 12, 2023
Viz.ai Wins Four Comparably Awards for Best Place to Work
Healthcare technology leader recognized for its culture, diversity, career growth and outlook SAN FRANCISCO - December 15, 2022 - Viz.ai,...
Dec 15, 2022
Viz.ai and Cercare Medical Partner to Support Neurovascular Clinical Decision Making
New partnership incorporates latest perfusion technology into the Viz.ai platform SAN FRANCISCO - November 29, 2022 - Viz.ai, the leader in AI-powered...
Nov 30, 2022
Viz.ai Launches AI-powered Viz™ Radiology Suite
Comprehensive solution tailored for radiologists to expedite patient diagnosis and treatment SAN FRANCISCO - November 28, 2022 - Viz.ai, the leader...
Nov 28, 2022